- Original brands
- The price on the pack
Privacy: may we measure how you found us? Never your name, number or health details.
May we remember how you found us, so we know which adverts are worth running? Allowing advertising also shares the value of a confirmed booking or payment, and the ad click it came from, with Google. We never share your name, contact details, medicines or anything about your health.

MRP, inclusive of all taxes
Delivered across India. ₹49 delivery, free above ₹999.
Pack: Tablet · 25mg + 5mg · 10`S
Prescription required — upload during checkout. No prescription? Place the order and a doctor will call you free of charge before it ships.
Original brandsFrom authorised sources
The price on the packNo inflated MRPs
Licensed pharmacyRx checked before packing
7 days to report a problemWrong or damaged item
Contains: Empagliflozin 25 mg + Linagliptin 5 mg tablet
Auroempa L 25/5 mg Tablet contains Empagliflozin 25 mg + Linagliptin 5 mg tablet. Prescription required.
We'll let you know the moment Auroempa L 25/5 mg Tablet is back in stock.
Auroempa L 25/5 mg Tablet is a prescription medicine containing Empagliflozin 25 mg + Linagliptin 5 mg tablet. It is used for type 2 diabetes mellitus: adjunct to diet. It belongs to the group of medicines called SGLT2 inhibitor + DPP-4 inhibitor combination.
Oral tablet. The dose and how long you take it depend on what you are being treated for and how you respond. Do not take more, or for longer, than your doctor has advised.
The side effects seen most often with Auroempa L 25/5 mg Tablet are increased urination, thirst, genital fungal infection and urinary tract infection. Most are mild and settle as the body gets used to the medicine. Tell your doctor if one persists or worries you.
Before you start, tell your doctor about any liver, kidney or heart problem, whether you are pregnant, planning a pregnancy or breastfeeding, and every other medicine you take, including supplements and ayurvedic preparations. Some of them can change how Auroempa L 25/5 mg Tablet works.
Type 2 diabetes mellitus: adjunct to diet and exercise to improve glycaemic control in adults when dual therapy is appropriate (including patients inadequately controlled on either component).
Most side effects of Auroempa L 25/5 mg are mild and settle as the body gets used to the medicine. The ones reported most often are:
Stop the medicine and get help at once for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.
Oral tablet. Usually taken once daily, with or without food, at the same time each day. Swallow whole with water; do not crush unless advised. Dose and duration as prescribed by a doctor; continue diet/exercise and regular glucose monitoring.
Empagliflozin is an SGLT2 inhibitor that lowers blood sugar by increasing urinary glucose excretion via the kidneys. Linagliptin is a DPP-4 inhibitor that increases incretin hormones, enhancing insulin release and reducing glucagon secretion in a glucose-dependent manner.
Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration/low blood pressure and acute kidney injury—maintain fluids; caution in elderly, diuretics, low BP, kidney disease. May increase risk of genital mycotic infections and UTIs; seek care for fever, flank pain, painful urination. Stop and seek urgent care if symptoms of ketoacidosis occur (nausea/vomiting, abdominal pain, rapid breathing) even if sugars are not very high. Rare risk of pancreatitis (persistent severe abdominal pain) and hypersensitivity with linagliptin. Temporarily withhold before major surgery/serious illness or prolonged fasting as advised. Kidney function should be assessed before and during therapy; not recommended in severe renal impairment/ESRD.
Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.
An overdose of this medicine can cause dehydration and a fall in blood pressure. It may cause low blood sugar, particularly if you also take other diabetes medicines. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.
Insulin and sulfonylureas (increased hypoglycaemia risk), diuretics (increased dehydration/hypotension risk), lithium (possible level changes with SGLT2 inhibitors), strong CYP3A4/P-gp inducers e.g., rifampicin, carbamazepine, phenytoin, phenobarbital, St John’s wort (may reduce linagliptin effect)
Store below 25°C in a cool, dry place. Protect from moisture and direct light. Keep in original blister pack and out of reach of children.
Glyxambi 25/5 Tablet, Jardiance Duo 25/5 Tablet, Empagliflozin 25 mg + Linagliptin 5 mg Tablets (generic equivalents), EmpaLin 25/5 Tablet, EmpaLina 25/5 Tablet
Compiled from the manufacturer's prescribing information and the sources below, and reviewed by a registered pharmacist. It does not replace your own doctor's advice.
Medical disclaimer: product information is for awareness only and does not replace medical advice. For Rx medicines, a valid prescription is required. Consult your doctor or pharmacist for personalised guidance.